QT dispersion and left ventricular function after stent placement in acute myocardial infarction

Hiroyasu Ueda1, Tomoshige Hayashi, Kei Tsumura

  • 1Department of Cardiology, Ishikiriseiki Hospital, 18-28, Yayoi, Higashiosaka, Osaka, 579-8026, Japan. hiroyasu-sayaka@joy.ocn.ne.jp

Insights

QT dispersion after acute myocardial infarction (AMI) treatment correlates with left ventricular ejection fraction (LVEF). Measurements at 24 and 48 hours post-procedure are key indicators of long-term LV function.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiovascular Imaging

Background:

  • QT dispersion increases in acute myocardial infarction (AMI).
  • The relationship between QT dispersion and left ventricular (LV) function post-AMI is not fully understood.
  • This study investigates QT dispersion and LV function after successful coronary stenting in AMI patients.

Purpose of the Study:

  • To evaluate the relationship between QT dispersion and LV function.
  • To assess this relationship in patients with AMI who underwent successful coronary stenting.

Main Methods:

  • Seventy-five AMI patients undergoing percutaneous transluminal coronary angioplasty (PTCA) were enrolled.
  • Corrected QT dispersion was measured at multiple time points: pre-PTCA, immediately post-PTCA, 24h, 48h, and 6 months.
  • Left ventricular ejection fraction (LVEF) was assessed by left ventriculography at 6 months post-PTCA.

Main Results:

  • Corrected QT dispersion at 24h and 48h post-PTCA showed significant correlations with LVEF by univariate analysis (p<0.05 and p<0.01).
  • Multiple regression analysis confirmed significant associations between corrected QT dispersion at 24h and 48h post-PTCA and LVEF (R²=0.441, p=0.006 and R²=0.411, p=0.039).
  • No significant association was found between LVEF and corrected QT dispersion measured before, immediately after, or 6 months after PTCA.

Conclusions:

  • Corrected QT dispersion measured 24 and 48 hours after PTCA in AMI patients correlates with LVEF at 6 months post-PTCA.
  • These findings suggest that early post-procedural QT dispersion may serve as a predictor of long-term LV function after successful coronary stenting in AMI.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...